Cell MedX Corp. (OTCMKTS:CMXC – Get Free Report)’s stock price crossed below its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of $0.41 and traded as low as $0.22. Cell MedX shares last traded at $0.30, with a volume of 204,286 shares trading hands.
Cell MedX Stock Performance
The company has a 50-day simple moving average of $0.40 and a 200-day simple moving average of $0.26.
Cell MedX Company Profile
Cell MedX Corp., a biotech company, discovers, develops, and commercializes therapeutic and non-therapeutic products for patients with diabetes, Parkinson’s disease, high blood pressure, neuropathy, and kidney functions in the United States. The company develops and manufactures eBalance Pro System for professional use by healthcare practitioners in a clinical setting; and eBalance Home System for home use for general wellness and pain management treatment, which are controlled by the eBalance Console that acts as the central controller for three pre-programmed microcurrent algorithms, including wellness, pain management, and dual.
Featured Articles
- Five stocks we like better than Cell MedX
- The Most Important Warren Buffett Stock for Investors: His Own
- Everything About Amazon Stock Signals a Buy—Time to Load Up?
- What is a Death Cross in Stocks?
- 5 Reasons Five Below’s Stock Price Is Heading Higher This Year
- How to Invest in the FAANG Stocks
- Broadcom: Why the Chip Stock Remains a Top Long-Term AI Play
Receive News & Ratings for Cell MedX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cell MedX and related companies with MarketBeat.com's FREE daily email newsletter.
